Undiagnosed Asymptomatic Hypoglycemia: Diet, Insulin, and Glyburide for Gestational Diabetic Pregnancy
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The role of maternal hypoglycemia during pregnancy has not yet been established. We sought to estimate the prevalence of undiagnosed, asymptomatic hypoglycemic events that occur in diabetic patients. METHODS: All patients were evaluated using a continuous glucose monitoring system for 72 consecutive hours. The continuous glucose monitoring system measures in subcutaneous tissue interstitial glucose levels within a range of 40-400 mg/dL every 5 minutes for a total of 288 measurements per day. All patients were instructed regarding diabetic diet and assigned to pharmacological treatment as needed. Patients documented the time of food intake, insulin or glyburide administration, and all clinical hypoglycemic events. An asymptomatic hypoglycemic episode was defined as more than 30 consecutive minutes of glucose value below 50 mg/dL detected only by continuous glucose monitoring system reading without patient awareness. RESULTS: An evaluation of 82 patients with gestational diabetes was performed; 30 were insulin-treated, 27 were managed by diet only, and 25 were patients treated with glyburide. For purposes of comparison, data were obtained from 35 nondiabetic gravid women. Asymptomatic hypoglycemic events were identified in 19 of 30 (63%) insulin-treated patients and in 7 of 25 (28%) glyburide-treated patients. No hypoglycemic events were identified in patients with gestational diabetes mellitus treated by diet alone or in nondiabetic subjects. The mean recorded hypoglycemic episodes per day was significantly higher in insulin-treated patients (4.2 +/- 2.1) than in glyburide-treated patients (2.1 +/- 1.1), P =.03. In insulin-treated patients, the majority of the hypoglycemic events were nocturnal (84%), whereas in glyburide-treated patients, episodes were identified equally by day and night. CONCLUSION: Our data suggest that asymptomatic hypoglycemic events are common during pharmacological treatment in gestational diabetic pregnancies. We speculate that this finding may be explained by treatment modality rather than by the disease itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · cited 1×
“Gestational diabetes mellitus was diagnosed according to the Carpenter and Coustan criteria.(17) Treatment modalities included diet alone or a combination of diet and insulin or glyburide.”
MethodA comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“We previously demonstrated that glyburide is as safe and efficient as insulin in the treatment of GDM, with no increased neonatal and maternal side effects.(19) Although glyburide-treated GDM patients did not differ from the insulin-treated GDM group by level of glycemic control, severity of GDM, age, prepregnancy wei…”
BackgroundSelf-citationLanger, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376
Self-citationThennadil, S. N., Rennert, J. L., Wenzel, B. J., Hazen, K. H., Ruchti, T. L., & Block, M. B. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/15209150152607132 · Cited by 166 · cited 1×
“The time delay between glucose values of venous plasma and subcutaneous concentrations is given with maximal 5 minutes.(18) The software for the download of the sensor data takes this delay into consideration, avoiding the need for further corrections.”
MethodROSENN, B., MIODOVNIK, M., HOLCBERG, G., KHOURY, J., & SIDDIQI, T. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00415-a · Cited by 161
Self-citationChen, R., Yogev, Y., Ben-Haroush, A., Jovanovic, L., Hod, M., & Phillip, M. (2003) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.14.4.256.260 · Cited by 101
Self-citation
Cited by
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Camelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000285 · Cited by 118
Predictors of glyburide failure in the treatment of gestational diabetes
Kahn, B. F., Davies, J. K., Lynch, A. M., Reynolds, R. M., & Barbour, L. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000218704.28313.36 · Cited by 85
“Maternal Treatment switch from glyburide to insulin 18 (19) Preeclampsia 11 (12) Mean gestational age (wk) at delivery 38 2 Cesarean delivery 24 (25) Maternal recurrent hypoglycemia 7 (7) Neonatal Mean birth weight (g) 3,309 499 Macrosomia 7 (7) Large for gestational age 25 (27) Shoulder dystocia 0 (0) Admission to NI…”
BackgroundThe use of glyburide in the management of gestational diabetes mellitus: A meta-analysis
Zeng, Y.-C., Li, M.-J., Chen, Y., Jiang, L., Wang, S.-M., Mo, X.-L., & Li, B.-Y. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.03.001 · Cited by 76
Paramasivam, S. S., Chinna, K., Singh, A. K. K., Ratnasingam, J., Ibrahim, L., Lim, L. L., Tan, A. T. B., Chan, S. P., Tan, P. C., Omar, S. Z., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13649 · Cited by 69
Metadata
- Authors
- Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., & Langer, O.
- Venue
- Obstetrics & Gynecology
- Published
- 2004-07
- Volume
- 104
- Issue
- 1
- Pages
- 88-93
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2042559024
- Cited by
- 82
- References
- 6
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Undiagnosed Asymptomatic Hypoglycemia: Diet, Insulin, and Glyburide for Gestational Diabetic Pregnancy. https://app.cochat.ai/papers/10.1097/01.aog.0000129239.82126.a1
- The paper
- Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., & Langer, O. (2004). Undiagnosed Asymptomatic Hypoglycemia: Diet, Insulin, and Glyburide for Gestational Diabetic Pregnancy. Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000129239.82126.a1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.